SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-059272
Filing Date
2023-07-24
Accepted
2023-07-24 17:25:11
Documents
1
Period of Report
2023-07-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1530
  Complete submission text file 0001213900-23-059272.txt   2897
Mailing Address C/O ARENA PHARMACEUTICALS, INC. 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Lisicki Robert (Reporting) CIK: 0001779614 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41596 | Film No.: 231105903

Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Issuer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations